Creo Medical Group Plc (CREO) Ord GBP0.001

- Add to watchlist
- Create an alert
- This stock can be held in a




19.00p
19.50p
40.25p
£78.37 million
19.00p
18.50p
12.63p
n/a
0.50p (2.70%) Previous:
0.50p
266,160
n/a
15,000
Performance
Not available for this stock.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue (£m) | 30.80 | 27.20 |
Profit before tax (£m) | (24.50) | (30.90) |
Adjusted EPS (p): | (7.00) | (14.48) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Director dealings: Creo Medical chairman raises stake
16 December 2024 15:27
-
Creo Medical extends closing date for retail offer
4 October 2024 16:10
-
Creo Medical reports year of solid progress
26 June 2024 13:43
-
First Welsh adopter of Speedboat® technology
6 February 2025 09:00
-
Total Voting Rights
3 February 2025 15:00
-
Award of Shares under Share Incentive Plan
21 January 2025 07:00
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.